bf/NASDAQ:SLRN_icon.jpeg

COM:ACELYRIN

Acelyrin, Inc.

  • Stock

Last Close

5.82

05/11 20:49

Market Cap

508.01M

Beta: -

Volume Today

329.00K

Avg: -

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, P...Show More

investor of